Navigation Links
Heartburn Drugs May Raise Pneumonia Risk

By Jenifer Goodwin
HealthDay Reporter

MONDAY, Dec. 20 (HealthDay News) -- Popular heartburn drugs, including proton pump inhibitors and histamine-2 receptor antagonists, may raise the risk of pneumonia, new research finds.

Researchers in Korea analyzed the results of 31 studies on heartburn drugs published between 1985 and 2009.

"Our results suggest that the use of acid suppressive drugs is associated with an increased risk of pneumonia," said Dr. Sang Min Park of the department of family medicine at Seoul National University Hospital in Korea.

"Patients should be cautious at overuse of acid-suppressive drugs, both high-dose and long duration," he added.

Sales of these enormously popular drugs -- the second best-selling category of medications worldwide -- reached nearly $27 billion in the United States in 2005, according to background information in the study, published Dec. 20 in CMAJ (Canadian Medical Association Journal).

Proton pump inhibitors (PPIs) reduce acid production in the stomach and are used to treat heartburn, gastroesophageal reflux disease (GERD) and gastric ulcers. They include omeprazole (Prilosec), lansoprazole (Prevacid) and esomeprazole (Nexium).

Histamine-2 receptor antagonists, often called H2 blockers, use a different mechanism to reduce stomach acid and include cimetidine (Tagamet), famotidine (Pepcid), nizatidine (Axid) and ranitidine (Zantac).

According to Consumer Reports, sales of a Nexium alone hit $4.8 billion in 2008.

Yet recently, studies have raised concerns about the drugs. Several studies have linked PPIs to a higher risk of fractures and an infection with a bacterium called Clostridium difficile.

Some previous studies also linked heartburn drugs to a higher risk of pneumonia, but the research has been mixed, according to the study authors.

Their meta-analysis combined the results of eight observational studies that found that taking PPIs increased the chances of developing pneumonia by 27 percent, while taking H2 blockers resulted in a 22 percent increased chance of pneumonia.

An analysis of 23 randomized clinical trials found people taking H2 blockers had a 22 percent increased chance of getting hospital-acquired pneumonia.

"Gastroenterologists in general have become more cognizant of the fact that these drugs can have some side effects," said Dr. Michael Brown, a gastroenterologist at Rush University Medical Center in Chicago. "For a long time, we were very happy to suppress people's acid without thinking about the consequences. Now we are starting to see some issues."

Hospital patients are often given acid-suppressing drugs, with studies showing them prescribed to as many as 40 to 70 percent of hospitalized patients. The authors suggest these drugs may be a cause of hospital-acquired pneumonia.

The rationale is that patients in intensive care units have decreased blood flow to the stomach, which can lead to ulcers and bleeding, a life-threatening condition that PPIs can prevent, Brown said.

The problem is that many patients prescribed the drugs in the hospital also go home with a prescription and continue taking PPIs, perhaps unnecessarily, Brown said.

According to the study, one in every 200 inpatients treated with acid-suppressing medications will develop pneumonia. The increased risk isn't huge, but it's still meaningful, Brown said.

"These drugs are given out like candy. You are talking about very large numbers of people taking the drugs," Brown said. "The study found a moderate increase in pneumonia, but, given the very large numbers of people who use these drugs, it's very significant."

The most plausible reason why suppressing acid in the stomach might raise the risk of pneumonia, Brown said, is that stomach acid acts as a barrier helping to control harmful bacteria and pathogens.

Not enough stomach acid to do the job may allow pathogens to flourish and end up in the lungs.

Yet no one is questioning the importance of PPIs and H2 blockers in treating GERD, said Dr. Jordan Josephson, an ear, nose and throat doctor at Lenox Hill Hospital in New York City. Reflux is painful and uncomfortable, and there's also debate among the scientific community as to whether it might increase the risk for a certain type of esophageal cancer. Research regarding the connection has had mixed results.

Reflux can also cause acids from the stomach to get into the airways and inflame the bronchial tubes, raising the risk of infection, he said.

"Not taking your PPIs can raise risk of bronchitis, sinusitis and maybe pneumonia," Josephson said. "I have a lot of patients on PPIs and H2 blockers and have never seen any of them end up with pneumonia as a result."

More information

The U.S. National Digestive Diseases Information Clearinghouse has more on GERD.

SOURCES: Sang Min Park, M.D., Ph.D., department of family medicine, Seoul National University Hospital, Seoul, Korea; Michael Brown, M.D., gastroenterologist, Rush University Medical Center, Chicago; Jordan Josephson, M.D., ear, nose and throat doctor, Lenox Hill Hospital, New York City; Dec. 20, 2010, CMAJ (Canadian Medical Association Journal)

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. For Most, Chronic Heartburn Not a Big Risk for Esophageal Cancer
2. No Link Between Heartburn Drugs and Birth Defects: Study
3. Heartburn Drugs, Plavix Seem Safe to Take Together
4. Plavix, Heartburn Drug Safe to Take Together: Study
5. FDA Warns of Fracture Risk With Popular Heartburn Drugs
6. Coming Soon: A Low-Heartburn Coffee?
7. Trio of drugs may combat triple negative breast cancer
8. Drugs are safe, active in patients normally ineligible for clinical trial
9. Certain Breast Cancer Drugs Linked With Heart Risks in Older Women
10. Economist honored for study on impact of new cancer drugs on life expectancy
11. FDA Panel Votes Against Drugs Said to Prevent Prostate Cancer
Post Your Comments:
Related Image:
Heartburn Drugs May Raise Pneumonia Risk
(Date:6/26/2016)... ... ... blind and certified personal trainer is helping to develop a weight loss fitness plan that ... the two major problems leading the fitness industry today:, , All ... They don’t eliminate all the reasons people quit their exercise program , ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due ... up a new, often overlooked aspect of head lice: the parasite’s ability to live away ... a common occurrence, but a necessary one in the event that lice have simply gotten ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Bracket , a leading ... next generation clinical outcomes platform, Bracket eCOA (SM) 6.0, ... June 26 – 30, 2016 in Philadelphia ... Clinical Outcome Assessment product of its kind to fully integrate ... Bracket eCOA 6.0 is a flexible platform for electronic ...
(Date:6/23/2016)... Ill. and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment ... Astellas Farma Brasil as the company,s second affiliate in Latin America . ... ... General Manager of Astellas Farma Colombia ... ...
(Date:6/23/2016)... 23, 2016 The vast majority of dialysis ... facility.  Treatments are usually 3 times a week, with ... including travel time, equipment preparation and wait time.  This ... grueling for patients who are elderly and frail.  Many ... and rehabilitation centers for some duration of time. ...
Breaking Medicine Technology: